BRUKER CORP (BRKR) Stock Fundamental Analysis

NASDAQ:BRKR • US1167941087

38.28 USD
-0.48 (-1.24%)
At close: Feb 20, 2026
52.84 USD
+14.56 (+38.04%)
After Hours: 2/20/2026, 8:19:43 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BRKR. BRKR was compared to 58 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. BRKR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BRKR had positive earnings in the past year.
  • BRKR had a positive operating cash flow in the past year.
  • Of the past 5 years BRKR 4 years were profitable.
  • In the past 5 years BRKR always reported a positive cash flow from operatings.
BRKR Yearly Net Income VS EBIT VS OCF VS FCFBRKR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • BRKR's Return On Assets of -0.36% is fine compared to the rest of the industry. BRKR outperforms 65.52% of its industry peers.
  • The Return On Equity of BRKR (-0.91%) is better than 65.52% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.69%, BRKR is in the better half of the industry, outperforming 70.69% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BRKR is below the industry average of 11.94%.
Industry RankSector Rank
ROA -0.36%
ROE -0.91%
ROIC 3.69%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.33%
ROIC(5y)9.58%
BRKR Yearly ROA, ROE, ROICBRKR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • With a decent Operating Margin value of 6.74%, BRKR is doing good in the industry, outperforming 63.79% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BRKR has declined.
  • Looking at the Gross Margin, with a value of 46.70%, BRKR is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • BRKR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.74%
PM (TTM) N/A
GM 46.7%
OM growth 3Y-35.88%
OM growth 5Y-18.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.84%
GM growth 5Y-0.59%
BRKR Yearly Profit, Operating, Gross MarginsBRKR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
  • The number of shares outstanding for BRKR remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for BRKR remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for BRKR has been reduced compared to a year ago.
BRKR Yearly Shares OutstandingBRKR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BRKR Yearly Total Debt VS Total AssetsBRKR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • The Debt to FCF ratio of BRKR is 134.47, which is on the high side as it means it would take BRKR, 134.47 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 134.47, BRKR perfoms like the industry average, outperforming 55.17% of the companies in the same industry.
  • BRKR has a Debt/Equity ratio of 0.75. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
  • BRKR has a worse Debt to Equity ratio (0.75) than 75.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 134.47
Altman-Z N/A
ROIC/WACC0.35
WACC10.48%
BRKR Yearly LT Debt VS Equity VS FCFBRKR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.73 indicates that BRKR should not have too much problems paying its short term obligations.
  • BRKR has a Current ratio of 1.73. This is in the lower half of the industry: BRKR underperforms 70.69% of its industry peers.
  • BRKR has a Quick Ratio of 1.73. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.87, BRKR is doing worse than 84.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.87
BRKR Yearly Current Assets VS Current LiabilitesBRKR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.07%.
  • BRKR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.27% yearly.
  • The Revenue has been growing slightly by 2.08% in the past year.
  • The Revenue has been growing by 11.57% on average over the past years. This is quite good.
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%

3.2 Future

  • BRKR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.20% yearly.
  • Based on estimates for the next years, BRKR will show a small growth in Revenue. The Revenue will grow by 3.22% on average per year.
EPS Next Y19.49%
EPS Next 2Y16.71%
EPS Next 3Y14.62%
EPS Next 5Y12.2%
Revenue Next Year4.16%
Revenue Next 2Y4.07%
Revenue Next 3Y4.4%
Revenue Next 5Y3.22%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRKR Yearly Revenue VS EstimatesBRKR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
BRKR Yearly EPS VS EstimatesBRKR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.92 indicates a rather expensive valuation of BRKR.
  • BRKR's Price/Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 82.76% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.99. BRKR is valued slightly cheaper when compared to this.
  • BRKR is valuated rather expensively with a Price/Forward Earnings ratio of 17.51.
  • BRKR's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 87.93% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.02, BRKR is valued a bit cheaper.
Industry RankSector Rank
PE 20.92
Fwd PE 17.51
BRKR Price Earnings VS Forward Price EarningsBRKR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKR indicates a somewhat cheap valuation: BRKR is cheaper than 79.31% of the companies listed in the same industry.
  • BRKR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 418.44
EV/EBITDA 16.34
BRKR Per share dataBRKR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • BRKR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BRKR's earnings are expected to grow with 14.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.07
PEG (5Y)3.33
EPS Next 2Y16.71%
EPS Next 3Y14.62%

5

5. Dividend

5.1 Amount

  • BRKR has a yearly dividend return of 0.52%, which is pretty low.
  • BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.10. BRKR pays more dividend than 91.38% of the companies in the same industry.
  • With a Dividend Yield of 0.52, BRKR pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

  • The dividend of BRKR is nicely growing with an annual growth rate of 6.16%!
  • BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years8
BRKR Yearly Dividends per shareBRKR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
  • The dividend of BRKR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-146.22%
EPS Next 2Y16.71%
EPS Next 3Y14.62%
BRKR Yearly Income VS Free CF VS DividendBRKR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

BRUKER CORP

NASDAQ:BRKR (2/20/2026, 8:19:43 PM)

After market: 52.84 +14.56 (+38.04%)

38.28

-0.48 (-1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-12
Earnings (Next)05-05
Inst Owners90.2%
Inst Owner Change-0.34%
Ins Owners26.95%
Ins Owner Change0.1%
Market Cap5.82B
Revenue(TTM)3.44B
Net Income(TTM)-22.50M
Analysts79.09
Price Target55.03 (43.76%)
Short Float %9.86%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.22
Dividend Growth(5Y)6.16%
DP-146.22%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.4%
Min EPS beat(2)-10.9%
Max EPS beat(2)31.69%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)1.39%
EPS beat(12)8
Avg EPS beat(12)4.7%
EPS beat(16)11
Avg EPS beat(16)5.48%
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)-0.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)1
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.64%
PT rev (1m)1.53%
PT rev (3m)15.96%
EPS NQ rev (1m)-43.77%
EPS NQ rev (3m)-46.91%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-5.27%
Revenue NQ rev (1m)-1.26%
Revenue NQ rev (3m)-2.45%
Revenue NY rev (1m)2.63%
Revenue NY rev (3m)2.16%
Valuation
Industry RankSector Rank
PE 20.92
Fwd PE 17.51
P/S 1.69
P/FCF 418.44
P/OCF 43.37
P/B 2.35
P/tB N/A
EV/EBITDA 16.34
EPS(TTM)1.83
EY4.78%
EPS(NY)2.19
Fwd EY5.71%
FCF(TTM)0.09
FCFY0.24%
OCF(TTM)0.88
OCFY2.31%
SpS22.62
BVpS16.28
TBVpS-5.33
PEG (NY)1.07
PEG (5Y)3.33
Graham Number25.89
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -0.91%
ROCE 4.67%
ROIC 3.69%
ROICexc 3.93%
ROICexgc 13.27%
OM 6.74%
PM (TTM) N/A
GM 46.7%
FCFM 0.4%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.33%
ROIC(5y)9.58%
ROICexc(3y)8.28%
ROICexc(5y)12.88%
ROICexgc(3y)16.23%
ROICexgc(5y)22.02%
ROCE(3y)9.28%
ROCE(5y)12.13%
ROICexgc growth 3Y-29.97%
ROICexgc growth 5Y-15.3%
ROICexc growth 3Y-45.99%
ROICexc growth 5Y-27.41%
OM growth 3Y-35.88%
OM growth 5Y-18.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.84%
GM growth 5Y-0.59%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 134.47
Debt/EBITDA 4.1
Cap/Depr 54.56%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 29.67%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.87
Altman-Z N/A
F-Score4
WACC10.48%
ROIC/WACC0.35
Cap/Depr(3y)70.11%
Cap/Depr(5y)91.82%
Cap/Sales(3y)3.51%
Cap/Sales(5y)3.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
EPS Next Y19.49%
EPS Next 2Y16.71%
EPS Next 3Y14.62%
EPS Next 5Y12.2%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%
Revenue Next Year4.16%
Revenue Next 2Y4.07%
Revenue Next 3Y4.4%
Revenue Next 5Y3.22%
EBIT growth 1Y-40.13%
EBIT growth 3Y-29%
EBIT growth 5Y-9.23%
EBIT Next Year50.4%
EBIT Next 3Y20.22%
EBIT Next 5Y17.98%
FCF growth 1Y-89.78%
FCF growth 3Y-54.25%
FCF growth 5Y-43.19%
OCF growth 1Y-46.64%
OCF growth 3Y-21.23%
OCF growth 5Y-16.59%

BRUKER CORP / BRKR FAQ

Can you provide the ChartMill fundamental rating for BRUKER CORP?

ChartMill assigns a fundamental rating of 4 / 10 to BRKR.


What is the valuation status for BRKR stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUKER CORP (BRKR). This can be considered as Fairly Valued.


Can you provide the profitability details for BRUKER CORP?

BRUKER CORP (BRKR) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BRKR stock?

The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 20.92 and the Price/Book (PB) ratio is 2.35.


What is the financial health of BRUKER CORP (BRKR) stock?

The financial health rating of BRUKER CORP (BRKR) is 2 / 10.